Orphan drug Clinical trial Incentive Rare disease Medicine Drug development Population Business Disease Public economics Drug Pharmacology Bioinformatics Environmental health Economics Pathology
Metrics
3
Cited By
2.69
FWCI (Field Weighted Citation Impact)
4
Refs
0.89
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Citation History
Topics
Genomics and Rare Diseases
Life Sciences → Biochemistry, Genetics and Molecular Biology → Genetics